GLP-1 (Semaglutide) - 5mg A synthetic glucagon-like peptide-1 (GLP-1) receptor agonist commonly utilized in laboratory research involving metabolic signaling, glucose regulation, appetite-associated pathways, and peptide-mediated cellular communication
News provided by University of Colorado Anschutz Jul 29, 2026, 00:00 ET A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
When you swallow a traditional pill, the acids and enzymes in your stomach often break the molecule down into its individual amino acids before it ever reaches your bloodstream
GLP-1 receptor agonists mimic this hormone, activating the same brain and digestive signals that control appetite and metabolism
Nitazines are synthetic opioids increasingly found in the illiict market and associated with a number of overdose deaths worldwide